CN106174563A - A kind of health product improving immunity of organisms - Google Patents
A kind of health product improving immunity of organisms Download PDFInfo
- Publication number
- CN106174563A CN106174563A CN201610555828.2A CN201610555828A CN106174563A CN 106174563 A CN106174563 A CN 106174563A CN 201610555828 A CN201610555828 A CN 201610555828A CN 106174563 A CN106174563 A CN 106174563A
- Authority
- CN
- China
- Prior art keywords
- parts
- health product
- raw material
- extract
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 40
- 230000036039 immunity Effects 0.000 title claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 25
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 19
- 229930064664 L-arginine Natural products 0.000 claims abstract description 19
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 19
- 235000009392 Vitis Nutrition 0.000 claims abstract description 16
- 241000219095 Vitis Species 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 13
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 13
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 13
- 239000002671 adjuvant Substances 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000001900 immune effect Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 23
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 241000282414 Homo sapiens Species 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- 108010006464 Hemolysin Proteins Proteins 0.000 description 5
- 239000003228 hemolysin Substances 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 206010057249 Phagocytosis Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000008782 phagocytosis Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000010428 Muscle Weakness Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229960003753 nitric oxide Drugs 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000006824 pyrimidine synthesis Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of health product improving immunity of organisms, it is made up of L-arginine 80 120 parts, Semen Vitis viniferae extract 40 60 parts, Radix Panacis Quinquefolii extract 70 80 parts, the raw material of 6 10 parts of zinc sulfate.These health product, with L-arginine, Semen Vitis viniferae extract, Radix Panacis Quinquefolii extract, zinc sulfate as primary raw material, add pharmaceutically acceptable adjuvant and are conventionally prepared from.By the synergistic function that each raw material is mutual, to improve resistance against diseases, to strengthen immune effect, alleviating physical fatigue, there is the feature of instant, safety and Health, stable curative effect.
Description
Technical field
The present invention relates to a kind of health product, a kind of health product improving immunity of organisms.
Background technology
At present, along with social competition is fierce, rhythm of life is fast, and life stress is big, and a lot of people are chronically at keen competition
Under the conditions of, daily life system is irregular, and diet is unbalanced, causes health to be in sub-health state, immunologic hypofunction, immunity
Reduce the strong influence health of human body, cause the generation of various disease.Modern medicine study shows, human body is ill
Reason is owing to autoimmune Force system goes wrong mostly, and immunity of organisms reduction causes, poor for body constitution, old
Disease, improve immunity of organisms there is important function.Improve medicine preparation and the health product of immunity in the market
Of a great variety, but effect is uneven.
Summary of the invention
For problems of the prior art, the invention provides a kind of health product improving immunity of organisms.This guarantor
Strong product, with L-arginine, Semen Vitis viniferae extract, Radix Panacis Quinquefolii extract, zinc sulfate as primary raw material, add pharmaceutically acceptable
Adjuvant be conventionally prepared from.By the synergistic function that each raw material is mutual, to improve resistance against diseases, to strengthen and exempt from
Epidemic disease effect, alleviating physical fatigue, have the feature of instant, safety and Health, stable curative effect.
The present invention is by the following technical solutions:
A kind of health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion: left-handed
Arginine 80-120 part, Semen Vitis viniferae extract 40-60 part, Radix Panacis Quinquefolii extract 70-80 part, zinc sulfate 6-10 part.
Preferably, the health product of described raising immunity, it is characterised in that it is by the raw material group of following weight portion
Become: L-arginine 100 parts, Semen Vitis viniferae extract 50 parts, Radix Panacis Quinquefolii extract 75 parts, 8 parts of zinc sulfate.
Preferably, the health product of described raising immunity, it is characterised in that with L-arginine, Semen Vitis viniferae extract,
Radix Panacis Quinquefolii extract, zinc sulfate are primary raw material, add the system that pharmaceutically acceptable adjuvant is conventionally prepared from
Agent.
The health product of described raising immunity, it is characterised in that after described each raw material weighs according to quantity, conventionally
Make capsule, tablet, granule or pill.
L-arginine (L-Arg) belongs to half necessary aminoacid, when health lacks, the resistance of disease can be died down, be fallen
Send out, muscle weakness, wound healing slowly, muscle weakness and male sterility etc. can be caused.L-arginine is except participating in tissue
Outside cell protein synthesis, also in carbamide, creatine, creatinine, nitric oxide (NO), glutamine, pyrimidine synthesis and release at hormone
Play a significant role in putting.In terms of threpsology's angle, L-Arg is not a kind of essential amino acids.In vivo, aspartic acid and paddy ammonia
Acid generates citrulline through transamination, and the latter follows ornithine cycle and generates L-Arg.But the synthesis of L-Arg is far from maintenance
The normal physiological activity of body needs, and human body takes in 5.4g L-Arg, especially some pathologic condition the most day by day under normal circumstances
Lower L-Arg requirement substantially increases.Supplement L-Arg and immunity, blood circulation and the hormonal system of body can be produced extensive shadow
Ring.L-Arg is except playing a significant role and affect immune system in addition in substance metabolism, and it or a kind of important immunity are adjusted
Joint material.
Semen Vitis viniferae extract is the new and effective natural anti-oxidation that can not synthesize in a kind of human body of extraction from Semen Vitis viniferae
Agent material.It is the antioxidation found in current nature, the material that Scavenging ability is the strongest, and its antioxidant activity is dimension
Raw element 50 times of E, ascorbic 20 times, the free radical that it is unnecessary in effectively removing human body, have superpower slow down aging and
The effect of enhancing immunity.Antioxidation, antiallergic, resisting fatigue health invigorating, improve sub-health state slow down aging, improve agitation
The symptoms such as irritability, dizzy weak, hypomnesis.
Radix Panacis Quinquefolii has the effects such as benefiting qi and nourishing blood, enriching yin and nourishing kidney, key spleen nourishing the stomach, slow down aging and skin care.Modern medicine grinds
Studying carefully proof, Radix Panacis Quinquefolii has resisting fatigue, defying age, shock, raising thinking, improves memory and endocrine regulation, enhancing human body
Immunity and improve the effect such as cardiovascular function.
Zinc is one of trace element of needed by human, important in growth in humans's growth, reproduction heredity, immunity, endocrine etc.
Physiological process plays an important role, by people titled with " flowers of life ", " source of intelligence ", the U.S. of " marriage harmony element "
Claim.Zinc is present in numerous enzyme systems, such as carbonic anhydrase, respiratory enzyme, lactate dehydrogenase, superoxide dismutase, alkaline phosphatase
During enzyme, DNA and RNA are poly-in enzyme etc., it is nucleic acid, protein, the synthesis of carbohydrate and the required material of vitamin A utilization.
There is enhancing development, improve the effect of the sense of taste.Easily occur during zinc deficiency that sense of taste olfactory sensation is poor, anorexia, poor growth are sent out with intelligence
Educate and wait performance less than normal.
The invention has the beneficial effects as follows: there is between each raw material of the present invention effect of mutual Synergistic, be remarkably improved machine
Body resistance against diseases, enhancing immune effect, alleviating physical fatigue, have the feature of instant, safety and Health, stable curative effect, its
Immunity improves effect and is significantly higher than the effect of any one-component, is highly suitable for modern vast sub-health population and eats for a long time
With.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail.
Embodiment 1
A kind of health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion: left-handed
Arginine 80 parts, Semen Vitis viniferae extract 40 parts, Radix Panacis Quinquefolii extract 70 parts, 6 parts of zinc sulfate.
Above-mentioned raw materials is added customary adjuvant conventional method according to conventional dose method and is prepared as tablet, 0.4g/ sheet.
Embodiment 2
A kind of health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion:
L-arginine 100 parts, Semen Vitis viniferae extract 50 parts, Radix Panacis Quinquefolii extract 75 parts, 8 parts of zinc sulfate.
Above-mentioned raw materials is added customary adjuvant conventional method according to conventional dose method and is prepared as capsule, 0.4g/
Grain.
Embodiment 3
A kind of health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion: left-handed
Arginine 120 parts, Semen Vitis viniferae extract 60 parts, Radix Panacis Quinquefolii extract 80 parts, 10 parts of zinc sulfate.
Above-mentioned raw materials is added customary adjuvant conventional method according to conventional dose method and is prepared as granule, 0.5g/
Bag.
Embodiment 4
A kind of health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion: left-handed
Arginine 110 parts, Semen Vitis viniferae extract 55 parts, Radix Panacis Quinquefolii extract 78 parts, 7 parts of zinc sulfate.
Above-mentioned raw materials is added customary adjuvant conventional method according to conventional dose method and is prepared as pill, 0.4g/ ball.
Immunologic function of the present invention is tested
Impact on Phagocytosis By The Peritoneal Macrophages In Mice
Taking mice 80, body weight, at 20-25g, is uniformly divided into 8 groups at random, test group 1-7 group, matched group the 8th group, test
The health product that above-described embodiment 1-4 prepares are mixed in normal diet by group 1-4 respectively, three times a day, and a 20mg；5th, 6,7 groups
Distinguishing feeding and test group L-arginine, Semen Vitis viniferae extract and the Radix Panacis Quinquefolii extract with dosage, feeding method is with test
Group；Matched group the 8th group mixes the starch of same dosage in normal diet, every day feeding 3 times, continuous 7 days.It is administered in last 1 time
Rear 1h, every mouse peritoneal injects 5% chicken red blood cell suspension 0.4ml, and after to chicken red blood cell, 4h puts to death mice, by tradition poison
Chicken red blood cell method in pharmacologic test surveys Phagocytosis By The Peritoneal Macrophages In Mice.Result of the test is shown in Table 1.
The table 1 impact on normal Phagocytosis By The Peritoneal Macrophages In Mice
| Group | Number of animals/only | Phagocytic percentage % | Phagocytic index |
| 1 | 10 | 69.2±4.2 | 0.91±0.71 |
| 2 | 10 | 75.3±5.1 | 0.99±0.82 |
| 3 | 10 | 70.1±3.9 | 0.95±0.91 |
| 4 | 10 | 73.5±4.5 | 0.97±0.88 |
| 5 | 10 | 57.2±4.0 | 0.72±0.69 |
| 6 | 10 | 56.9±3.5 | 0.82±0.71 |
| 7 | 10 | 53.2±4.1 | 0.69±0.51 |
| 8 | 10 | 40.2±3.2 | 0.60±0.76 |
The impact that normal mouse hemolysin is formed
Mouse species number, be grouped, be administered all the same, in being administered the 1st day, every Mus lumbar injection 5% chicken red blood cell physiology salt
Aqueous suspension 0.2ml carries out immunity, and after last after medicine 2h, mouse orbit takes blood, examines by serum hemolysin spectrophotometric
Survey method surveys hemolysin formational situation.
The impact that normal mouse hemolysis plaque is formed
Mouse species number, it is grouped, is administered and immunity is all the same, 2h after last administration, mice is taken off cervical vertebra and puts to death,
Dissect and take out spleen, two mouse spleens are put together and is homogenized, by Traditional pharmacological testing inspection hemolysis plaque by homogenizer
Method detects this test formational situation.
The impact that normal mouse lymphocyte is converted
Mouse species number, be grouped, be administered all the same, in first 3 days be administered, every mice intramuscular injection every day plant blood clotting
Element 8mg/kg, 2h after last administration, mice cuts tail and takes blood, push jack, and Switzerland's dye liquor dyeing, with oil sem observation periphery stranguria with blood
Bar cell transformation rate.Result of the test is shown in Table 2.
The table 2 impact on the conversion of normal mouse hemolysin, hemolysis plaque formation and lymphocyte
The data of contrast Tables 1 and 2, we are it is found that Turnover of Mouse Peritoneal Macrophages is swallowed by the health product of the present invention
Function, mice hemolysin, hemolysis plaque are formed and the conversion aspect of lymphocyte is respectively provided with preferable immune effect, and will compare
Single composition of raw materials has more preferable immunologic function, and this is mainly due to reasonable raw material proportioning of the present invention, collaborative between each raw material
Effect, significantly improves the immunocompetence of body, alleviating physical fatigue.
The health product of the present invention are carried out clinical trial applied research
Clinical data: randomly selecting the patient of 300 example hypoimmunities, the maleest 180 examples, female 120 example, age distribution exists
10-75 year, patient take the embodiment of the present invention 2 preparation capsule, three times a day, each 2, after taking continuously one month observe
Clinical effectiveness.
Effective evaluation standard:
Effective: body constitution is remarkably reinforced, extremity are strong, and energy and face have taken a turn for the better, and sleep and the Asia of the aspect such as digestion
Health status is obviously improved；
Taking a turn for the better: body constitution has strengthened, and extremity are more powerful, energetic, face improves, and sleeps and the Asia of the aspect such as digestion is good for
Health state also makes moderate progress；
Invalid: symptom and every inspection have no improvement.
Therapeutic outcome: result shows by clinical observation, the most effective example 275 example, account for 91.7%；Improvement example 24 example, accounts for
8%；Invalid example 1 example, accounts for 0.3%；Total effective rate reaches 99.7%.The patient of all uses health product of the present invention all without any not
Good reaction and malaise symptoms.
Example 1: Lee, man, 17 years old, high school senior, owing to high three learning pressures increase the weight of, just adds body constitution own
Difference, so usually feeling dizzy weak, have a sleepless night in the evening, feels sleepy daytime, attends class and cannot concentrate on, has had a strong impact on his review
Appendix.Taking health product of the present invention after one month, above-mentioned symptom is obviously improved, and can sleep sound in the evening, and daytime also can concentrate essence
God attends class, and then continues to take two months, and above-mentioned symptom is wholly absent, and body constitution has had the biggest improvement than before.
Example 2: Cai so-and-so, female, 25 years old, city white collar, because being busy with one's work, it is often necessary to works extra shifts or extra hours, stay up late all night,
To such an extent as to health occurs in that sub-health state, work always cannot be concentrated on, and slightly does something and just feels tired out, goes to hospital
Check and the most do not find what organic disease.After taking health product two weeks of the present invention, spirit is obviously improved, and sense tired out is
The strongest, after taking January, the recovery of energy can be clearly felt that, continue to take health product of the present invention afterwards and consolidate,
Health obtains the biggest improvement, works energetic.
Example 3: Lin, man, 65 years old, due to the increase at age, every function of health fell into a decline, and body constitution reduces, food
It is intended to the symptoms such as depressed, sleep disorder and annoyings him always.Taking health product of the present invention after one month, appetite substantially increases, sleep
Might as well be a lot, after persistently take health product of the present invention, contrast the old people with age bracket, body constitution significantly improves a lot.
Claims (4)
1. the health product improving immunity of organisms, it is characterised in that it is made up of the raw material of following weight portion: left-handed essence
Propylhomoserin 80-120 part, Semen Vitis viniferae extract 40-60 part, Radix Panacis Quinquefolii extract 70-80 part, zinc sulfate 6-10 part.
The health product of raising immunity the most according to claim 1, it is characterised in that it is by the raw material of following weight portion
Composition: L-arginine 100 parts, Semen Vitis viniferae extract 50 parts, Radix Panacis Quinquefolii extract 75 parts, 8 parts of zinc sulfate.
The health product of raising immunity the most according to claim 1 and 2, it is characterised in that with L-arginine, Semen Vitis viniferae
Extract, Radix Panacis Quinquefolii extract, zinc sulfate are primary raw material, add pharmaceutically acceptable adjuvant conventionally prepare and
The preparation become.
The health product of raising immunity the most according to claim 3, it is characterised in that after described each raw material weighs according to quantity,
Conventionally make capsule, tablet, granule or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610555828.2A CN106174563A (en) | 2016-07-15 | 2016-07-15 | A kind of health product improving immunity of organisms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610555828.2A CN106174563A (en) | 2016-07-15 | 2016-07-15 | A kind of health product improving immunity of organisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106174563A true CN106174563A (en) | 2016-12-07 |
Family
ID=57474326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610555828.2A Pending CN106174563A (en) | 2016-07-15 | 2016-07-15 | A kind of health product improving immunity of organisms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106174563A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279443A (en) * | 2017-08-23 | 2017-10-24 | 何玉松 | A kind of pressed candy and preparation method thereof |
| CN108771246A (en) * | 2018-07-01 | 2018-11-09 | 江西天元药业有限公司 | It improves the immunity of patient after postoperative or chemotherapy and restores the composition of physiological function |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101128209A (en) * | 2004-12-24 | 2008-02-20 | 都菲斯特股份有限公司 | Formula ions and treatments for well-being |
| CN102293430A (en) * | 2011-06-24 | 2011-12-28 | 于光远 | Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof |
| CN105327025A (en) * | 2015-12-08 | 2016-02-17 | 天津中新药业集团股份有限公司第六中药厂 | Preparation method of composition capable of relieving physical fatigue |
| CN105361171A (en) * | 2015-12-08 | 2016-03-02 | 天津中新药业集团股份有限公司第六中药厂 | Composition with physical fatigue-relieving effect |
-
2016
- 2016-07-15 CN CN201610555828.2A patent/CN106174563A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101128209A (en) * | 2004-12-24 | 2008-02-20 | 都菲斯特股份有限公司 | Formula ions and treatments for well-being |
| CN102293430A (en) * | 2011-06-24 | 2011-12-28 | 于光远 | Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof |
| CN105327025A (en) * | 2015-12-08 | 2016-02-17 | 天津中新药业集团股份有限公司第六中药厂 | Preparation method of composition capable of relieving physical fatigue |
| CN105361171A (en) * | 2015-12-08 | 2016-03-02 | 天津中新药业集团股份有限公司第六中药厂 | Composition with physical fatigue-relieving effect |
Non-Patent Citations (2)
| Title |
|---|
| 张文栋 等: "《实用体能训练营养学》", 31 January 2014, 人民体育出版社 * |
| 甘智荣: "《滋补全家的养生菜》", 28 February 2015, 吉林科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279443A (en) * | 2017-08-23 | 2017-10-24 | 何玉松 | A kind of pressed candy and preparation method thereof |
| CN108771246A (en) * | 2018-07-01 | 2018-11-09 | 江西天元药业有限公司 | It improves the immunity of patient after postoperative or chemotherapy and restores the composition of physiological function |
| CN108771246B (en) * | 2018-07-01 | 2021-06-01 | 江西天元药业有限公司 | Composition for improving immunity and restoring physiological function of patients after operation or chemotherapy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6193973B1 (en) | Dietary supplement for boosting energy and increasing muscular strength | |
| CN101574140B (en) | Drink composition with human immunity strengthening and anti-fatigue functions | |
| CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
| CN1927383B (en) | Compound recipe preparation for lowering oxidative stress rapidly and preparation method therefor | |
| CN107581255A (en) | A kind of composition for improving sleep quality and preparation method thereof | |
| CN104432035B (en) | The health nutrient composition and method of making the same of enhancing immunity and application | |
| CN101637265B (en) | Health food used for improving sleeping | |
| CN102499291B (en) | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof | |
| CN102716315A (en) | Kidney yang tonifying health care medicinal liquor and preparation method thereof | |
| US20170209486A1 (en) | Health-care preparation simultaneously with magnesium supplement and antioxidant functions and preparation method thereof | |
| CN106174563A (en) | A kind of health product improving immunity of organisms | |
| CN100405921C (en) | Health food capable of resisting fatigue | |
| CN101703296A (en) | Pleurotus citrinopileatus drink and preparation method thereof | |
| CN103005435B (en) | Anti-fatigue composition capable of improving speed endurance and preparation containing anti-fatigue composition | |
| CN108143974A (en) | Relieving alcoholism and protecting liver ball | |
| CN102008083B (en) | Health food for alleviating physical fatigue and removing chloasma | |
| JPH07196523A (en) | Solution for internal use containing quercetin glycoside | |
| CN109744543A (en) | A kind of bone collagen peptide composite powder and preparation method thereof | |
| CN102204676A (en) | Food for resisting sleep deprivation stress damage | |
| CN103584092A (en) | Health-care composition | |
| CN106176929A (en) | A kind of health product being improved immunity of organisms and antihypertensive function by regulation and control content of nitric oxide technology | |
| CN101091720A (en) | Health food with efficacy for preventing osteoporosis and preparation method | |
| CN102949424A (en) | Medicinal composition for relieving physical fatigue and preparation method thereof | |
| CN104146271A (en) | Metabolism regulating and liver protecting nutritional supplement, preparation method and applications thereof | |
| CN106109541A (en) | A kind of health product improving immunity of organisms, resisting fatigue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170519 Address after: Qing Ping Road Qingpu District Xujing town Shanghai City Luzhou 201700 No. 2008 floor 10 room 1025 Applicant after: SHANGHAI NO-TOP BIOTECHNOLOGY CO., LTD. Address before: 200030 Shanghai city Xuhui District Yunjin Road No. 500 Green Exchange Center B building 17 floor Applicant before: Zhang Biao |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20190121 Address after: 511442 Room 602, 4 Building, 383 North Panyu Avenue, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant after: Guangzhou Sansan Medical Biotechnology Co., Ltd. Address before: Room 1025, 10th floor, 2008 Luqingping Road, Xujing Town, Qingpu District, Shanghai Applicant before: SHANGHAI NO-TOP BIOTECHNOLOGY CO., LTD. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |
|
| RJ01 | Rejection of invention patent application after publication |